Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.120 CAD | -13.96% |
|
-14.85% | -14.37% |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 75.79M | 67.36M | 66.2M | 73.85M | 109M | |||||
Total Revenues | 75.79M | 67.36M | 66.2M | 73.85M | 109M | |||||
Cost of Goods Sold, Total | 18.13M | 16.62M | 16M | 17.16M | 17.22M | |||||
Gross Profit | 57.66M | 50.75M | 50.21M | 56.68M | 91.46M | |||||
Selling General & Admin Expenses, Total | 6.66M | 6.79M | 7.42M | 12.68M | 33.79M | |||||
R&D Expenses | 19.24M | 18.85M | 16.7M | 18.14M | 23.68M | |||||
Other Operating Expenses, Total | 25.91M | 25.64M | 24.13M | 30.82M | 57.47M | |||||
Operating Income | 31.75M | 25.11M | 26.08M | 25.86M | 33.98M | |||||
Interest Expense, Total | -2.13M | -2.07M | -2M | -1.93M | -1.91M | |||||
Interest And Investment Income | 1.13M | 374K | 440K | 1.81M | 3.1M | |||||
Net Interest Expenses | -1M | -1.7M | -1.56M | -122K | 1.19M | |||||
Currency Exchange Gains (Loss) | 1.71M | -1.94M | -495K | 910K | 50K | |||||
EBT, Excl. Unusual Items | 32.46M | 21.47M | 24.02M | 26.65M | 35.22M | |||||
Other Unusual Items | - | 5.45M | - | - | - | |||||
EBT, Incl. Unusual Items | 32.46M | 26.92M | 24.02M | 26.65M | 35.22M | |||||
Income Tax Expense | 8.97M | 6.73M | 5.62M | 6.85M | 8.96M | |||||
Earnings From Continuing Operations | 23.48M | 20.19M | 18.4M | 19.8M | 26.26M | |||||
Net Income to Company | 23.48M | 20.19M | 18.4M | 19.8M | 26.26M | |||||
Net Income - (IS) | 23.48M | 20.19M | 18.4M | 19.8M | 26.26M | |||||
Net Income to Common Incl Extra Items | 23.48M | 20.19M | 18.4M | 19.8M | 26.26M | |||||
Net Income to Common Excl. Extra Items | 23.48M | 20.19M | 18.4M | 19.8M | 26.26M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.29 | 0.25 | 0.23 | 0.25 | 0.32 | |||||
Basic EPS - Continuing Operations | 0.29 | 0.25 | 0.23 | 0.25 | 0.32 | |||||
Basic Weighted Average Shares Outstanding | 80.24M | 80.27M | 80.32M | 80.46M | 80.98M | |||||
Net EPS - Diluted | 0.29 | 0.25 | 0.23 | 0.24 | 0.32 | |||||
Diluted EPS - Continuing Operations | 0.29 | 0.25 | 0.23 | 0.24 | 0.32 | |||||
Diluted Weighted Average Shares Outstanding | 80.44M | 80.48M | 80.61M | 81.1M | 83.11M | |||||
Normalized Basic EPS | 0.25 | 0.17 | 0.19 | 0.21 | 0.27 | |||||
Normalized Diluted EPS | 0.25 | 0.17 | 0.19 | 0.21 | 0.26 | |||||
Dividend Per Share | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Payout Ratio | 136.67 | 79.52 | 87.28 | 81.32 | 61.72 | |||||
Supplemental Items | ||||||||||
EBITDA | 33.74M | 26.99M | 27.9M | 27.13M | 36.68M | |||||
EBITA | 31.75M | 25.11M | 26.08M | 25.88M | 35.48M | |||||
EBIT | 31.75M | 25.11M | 26.08M | 25.86M | 33.98M | |||||
EBITDAR | 35.08M | 28.02M | 28.94M | 28.15M | 38.03M | |||||
Effective Tax Rate - (Ratio) | 27.64 | 25.01 | 23.38 | 25.71 | 25.45 | |||||
Total Current Taxes | 8.98M | 7.56M | 6M | 7.09M | 5.45M | |||||
Total Deferred Taxes | -13K | -831K | -386K | -235K | 3.52M | |||||
Normalized Net Income | 20.28M | 13.42M | 15.01M | 16.66M | 22.01M | |||||
Interest on Long-Term Debt | 2.13M | 2.07M | 2M | 1.93M | 1.91M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | - | - | - | - | 14.96M | |||||
General and Administrative Expenses | 6.66M | 6.79M | 7.42M | 12.68M | 18.84M | |||||
Research And Development Expense From Footnotes | 20.75M | 15.86M | 17.58M | 18.14M | 24.02M | |||||
Net Rental Expense, Total | 1.34M | 1.03M | 1.04M | 1.02M | 1.35M | |||||
Imputed Operating Lease Interest Expense | - | 411K | 415K | 408K | 552K | |||||
Imputed Operating Lease Depreciation | - | 622K | 627K | 617K | 802K | |||||
Stock-Based Comp., R&D Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 1.38M | 3.45M | 2.47M | 3.32M | 6.29M | |||||
Total Stock-Based Compensation | 1.38M | 3.45M | 2.47M | 3.32M | 6.29M |